n Cardiovascular Journal of Africa - Bayer's Xarelto® is approved in South Africa across five additional indications - advertorial : drug trends in cardiology
|Article Title||Bayer's Xarelto® is approved in South Africa across five additional indications - advertorial : drug trends in cardiology|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of Africa|
|Publication Date||Mar 2014|
|Pages||90 - 92|
Bayer HealthCare's oral anticoagulant Xarelto® 15 and 20 (rivaroxaban) has been approved by the Medicines Control Council of South Africa for use in five new indications, making it the only new oral anticoagulant approved in six indications across the world.
Article metrics loading...